Unknown PHASE4 INTERVENTIONAL 2-arm NCT05712616

Role of Strontium Ranelate in Proximal Femur Fragility Fractures. (STRONG)

Role of Strontium Ranelate in Radiological Healing of Proximal Femur Fractures. A Phase IV Double Blinded Randomized Controlled Trial

Sponsor: AO Trauma Middle East and North Africa

Conditions Clinical Trial Femur; Fracture, Pertrochanteric Fragility Fracture

Interventions Lacto-N-Hexaose Strontium Ranelate

Updated 4 times since 2023 Last updated: Feb 1, 2023 Started: Nov 1, 2021 Primary completion: Nov 30, 2023 Completion: Jun 30, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Clinical Trial and Femur; Fracture, Pertrochanteric, this trial is ongoing. The trial is conducted by AO Trauma Middle East and North Africa and has accumulated 4 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Mar 2025 — Present [monthly]

Unknown PHASE4

Status: Recruiting → Unknown
Sep 2024 — Mar 2025 [monthly]

Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE4
Mar 2023 — Jul 2024 [monthly]

Recruiting PHASE4

First recorded

Nov 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

AO Trauma Middle East and North Africa
Aga Khan University Hospital, Pakistan

Data source: Aga Khan University Hospital, Pakistan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan